Matches in SemOpenAlex for { <https://semopenalex.org/work/W1844713816> ?p ?o ?g. }
- W1844713816 endingPage "225" @default.
- W1844713816 startingPage "213" @default.
- W1844713816 abstract "Sigma (σ) receptors have generated a great deal of interest due to their possible role in psychosis, neuroprotection, and various other behaviors including addictive processes. Sigma receptors have been located in brain areas involved in motor functions, including the dopaminergic projections from the substantia nigra to the striatum. Evidence suggests that one of their major roles might be to regulate the activity of the glutamatergic system via the N-methyl-d-aspartate receptor. The sigma receptor agonist 1,3-di-o-tolyl-guanidine (DTG) was found to increase dopamine release in the striatum, nucleus accumbens, and prefrontal cortex, in a dose-dependent manner, after central as well as peripheral administration, suggesting a modulatory role of these receptors on the dopaminergic system. The present study examines whether chronic administration of the DTG sigma agonist induces neuromorphological and behavioral changes in neonatal ventral hippocampal lesioned (nVHL) rats as a neurodevelopmental model of schizophrenia. The results show that the DTG administration reduces the hyperlocomotor activity in nVHL rats and reverses the neuronal hypotrophy generated in nVHL rats in the prefrontal cortex, amygdala, and nucleus accumbens. Our results demonstrate that DTG, a sigma-1 receptor agonist, reverses some of the behavioral and neuromorphological effects of nVHL on the rat and supports the possibility that DTG may have beneficial effects in the management of symptoms of schizophrenia. Synapse, 69:213–225, 2015. © 2015 Wiley Periodicals, Inc." @default.
- W1844713816 created "2016-06-24" @default.
- W1844713816 creator A5012752153 @default.
- W1844713816 creator A5018660466 @default.
- W1844713816 creator A5022768721 @default.
- W1844713816 creator A5027226585 @default.
- W1844713816 creator A5030694671 @default.
- W1844713816 creator A5033466107 @default.
- W1844713816 creator A5060148592 @default.
- W1844713816 creator A5064225563 @default.
- W1844713816 creator A5065965357 @default.
- W1844713816 creator A5076127344 @default.
- W1844713816 date "2015-02-28" @default.
- W1844713816 modified "2023-09-27" @default.
- W1844713816 title "The sigma agonist 1,3-Di-<i>o</i>-tolyl-guanidine reduces the morphological and behavioral changes induced by neonatal ventral hippocampus lesion in rats" @default.
- W1844713816 cites W144919433 @default.
- W1844713816 cites W1597954511 @default.
- W1844713816 cites W1882365212 @default.
- W1844713816 cites W1932137403 @default.
- W1844713816 cites W1963512328 @default.
- W1844713816 cites W1964765468 @default.
- W1844713816 cites W1969236553 @default.
- W1844713816 cites W1972793459 @default.
- W1844713816 cites W1975682905 @default.
- W1844713816 cites W1979055305 @default.
- W1844713816 cites W1979328277 @default.
- W1844713816 cites W1979649103 @default.
- W1844713816 cites W1981373150 @default.
- W1844713816 cites W1983783535 @default.
- W1844713816 cites W1983823375 @default.
- W1844713816 cites W1986007035 @default.
- W1844713816 cites W1990035343 @default.
- W1844713816 cites W1991402871 @default.
- W1844713816 cites W1992763610 @default.
- W1844713816 cites W1992768650 @default.
- W1844713816 cites W1993523558 @default.
- W1844713816 cites W1994224293 @default.
- W1844713816 cites W2010963787 @default.
- W1844713816 cites W2012245779 @default.
- W1844713816 cites W2012724801 @default.
- W1844713816 cites W2018800927 @default.
- W1844713816 cites W2019024937 @default.
- W1844713816 cites W2019079031 @default.
- W1844713816 cites W2019320775 @default.
- W1844713816 cites W2022496892 @default.
- W1844713816 cites W2023120488 @default.
- W1844713816 cites W2028496416 @default.
- W1844713816 cites W2029815260 @default.
- W1844713816 cites W2036180008 @default.
- W1844713816 cites W2038360643 @default.
- W1844713816 cites W2040973454 @default.
- W1844713816 cites W2040991643 @default.
- W1844713816 cites W2042500234 @default.
- W1844713816 cites W2045492160 @default.
- W1844713816 cites W2046332382 @default.
- W1844713816 cites W2048338025 @default.
- W1844713816 cites W2049136780 @default.
- W1844713816 cites W2049331812 @default.
- W1844713816 cites W2055140006 @default.
- W1844713816 cites W2057892969 @default.
- W1844713816 cites W2058495283 @default.
- W1844713816 cites W2060468971 @default.
- W1844713816 cites W2061554186 @default.
- W1844713816 cites W2061633232 @default.
- W1844713816 cites W2062502420 @default.
- W1844713816 cites W2067388722 @default.
- W1844713816 cites W2072272005 @default.
- W1844713816 cites W2072816846 @default.
- W1844713816 cites W2073373337 @default.
- W1844713816 cites W2074697000 @default.
- W1844713816 cites W2083105433 @default.
- W1844713816 cites W2083876585 @default.
- W1844713816 cites W2087680546 @default.
- W1844713816 cites W2094428711 @default.
- W1844713816 cites W2097243895 @default.
- W1844713816 cites W2097902735 @default.
- W1844713816 cites W2107854911 @default.
- W1844713816 cites W2112800950 @default.
- W1844713816 cites W2118955023 @default.
- W1844713816 cites W2126300446 @default.
- W1844713816 cites W2127749802 @default.
- W1844713816 cites W2137454401 @default.
- W1844713816 cites W2148418924 @default.
- W1844713816 cites W2156035025 @default.
- W1844713816 cites W2156371463 @default.
- W1844713816 cites W2156975935 @default.
- W1844713816 cites W2158527872 @default.
- W1844713816 cites W2162836113 @default.
- W1844713816 cites W2164990755 @default.
- W1844713816 doi "https://doi.org/10.1002/syn.21811" @default.
- W1844713816 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25682743" @default.
- W1844713816 hasPublicationYear "2015" @default.
- W1844713816 type Work @default.
- W1844713816 sameAs 1844713816 @default.
- W1844713816 citedByCount "7" @default.
- W1844713816 countsByYear W18447138162015 @default.
- W1844713816 countsByYear W18447138162016 @default.
- W1844713816 countsByYear W18447138162017 @default.